Literature DB >> 29734489

Diagnostic performance of intravoxel incoherent motion diffusion-weighted imaging in the assessment of the dynamic status of myocardial perfusion.

Dong-Aolei An1, Bing-Hua Chen1, Ruo-Yang Shi1, Jun Bu2, Heng Ge2, Jiani Hu3, Jian-Rong Xu1, Lian-Ming Wu1.   

Abstract

BACKGROUND: Acute myocardial infarction (AMI) is a major cause of morbidity and mortality worldwide and places a significant financial burden on our society.
PURPOSE: To determine the feasibility of cardiac intravoxel incoherent motion (IVIM) in the consecutive evaluation of myocardial perfusion in myocardial infarction patients postpercutaneous coronary intervention (PCI) and to investigate the dynamic biological phenomena in myocardial perfusion after AMI. STUDY TYPE: Prospective observational study. POPULATION: Twenty ST-segment elevation myocardial infarction (STEMI) patients after reperfusion therapy and 12 healthy volunteers served as controls. FIELD STRENGTH/SEQUENCE: Cardiac MRI at 3T, including steady-state free precession (SSFP) cine imaging, T2 -short time inversion recovery (T2 -STIR), late gadolinium enhancement (LGE), T2 mapping, and IVIM diffusion-weighted imaging (DWI) were performed. ASSESSMENT: Myocardial T2 value and IVIM-DWI-associated parameters (ADCfast , ADCslow , and f value) of the infarcted myocardium at different timepoints, remote myocardium, and normal myocardium were analyzed by two experienced radiologists. STATISTICAL TESTS: Independent sample's t-test, Pearson's, and Spearman's correlation and interobserver variability were applied. P ≤ 0.05 was considered significant.
RESULTS: The T2 value in ischemic myocardium measured on day 3 (73.58 ± 4.37 msec) was greater than at any other timepoint (24 hours, day 7, day 30; 66.66 ± 4.71 msec, 68.36 ± 4.18 msec, 64.98 ± 5.39 msec, respectively, P < 0.001). ADCfast and f values were significantly lower in ischemic myocardium than in the remote myocardium as well. The f value in ischemic myocardium at day 3 (0.0989 ± 0.02) was lower than at any other timepoint (24 hours, 7 day, 30 day; 0.1203 ± 0.02, 0.1109 ± 0.02, 0.1213 ± 0.02, respectively, P < 0.001. DATA
CONCLUSION: This preliminary study demonstrated that a dynamic process exists in the status of myocardial edema and myocardial perfusion in MI patients after PCI. The findings suggest myocardial perfusion would be best evaluated between day 3 and day 7. LEVEL OF EVIDENCE: 2 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2018;48:1602-1609.
© 2018 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  AMI; IVIM; T2 mapping; late gadolinium enhanced imaging

Mesh:

Substances:

Year:  2018        PMID: 29734489     DOI: 10.1002/jmri.26179

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  3 in total

Review 1.  Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials: JACC Scientific Expert Panel.

Authors:  Borja Ibanez; Anthony H Aletras; Andrew E Arai; Hakan Arheden; Jeroen Bax; Colin Berry; Chiara Bucciarelli-Ducci; Pierre Croisille; Erica Dall'Armellina; Rohan Dharmakumar; Ingo Eitel; Rodrigo Fernández-Jiménez; Matthias G Friedrich; David García-Dorado; Derek J Hausenloy; Raymond J Kim; Sebastian Kozerke; Christopher M Kramer; Michael Salerno; Javier Sánchez-González; Javier Sanz; Valentin Fuster
Journal:  J Am Coll Cardiol       Date:  2019-07-16       Impact factor: 24.094

2.  Effect of the WeChat Platform Health Management and Refined Continuous Nursing Model on Life Quality of Patients with Acute Myocardial Infarction after PCI.

Authors:  Meifang Xu; Xiaofang Yang; Lin Liu; Yunlang Dai; Mingzhu Xu; Shi Lin
Journal:  J Healthc Eng       Date:  2021-11-29       Impact factor: 2.682

3.  Cardiovascular magnetic resonance native T2 and T2* quantitative values for cardiomyopathies and heart transplantations: a systematic review and meta-analysis.

Authors:  G J H Snel; M van den Boomen; L M Hernandez; C T Nguyen; D E Sosnovik; B K Velthuis; R H J A Slart; R J H Borra; N H J Prakken
Journal:  J Cardiovasc Magn Reson       Date:  2020-05-11       Impact factor: 5.364

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.